rs112318500

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_139343.3(BIN1):​c.1595C>T​(p.Thr532Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00526 in 1,614,214 control chromosomes in the GnomAD database, including 355 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T532K) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.028 ( 182 hom., cov: 34)
Exomes 𝑓: 0.0028 ( 173 hom. )

Consequence

BIN1
NM_139343.3 missense

Scores

6
12

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 1.80

Publications

15 publications found
Variant links:
Genes affected
BIN1 (HGNC:1052): (bridging integrator 1) This gene encodes several isoforms of a nucleocytoplasmic adaptor protein, one of which was initially identified as a MYC-interacting protein with features of a tumor suppressor. Isoforms that are expressed in the central nervous system may be involved in synaptic vesicle endocytosis and may interact with dynamin, synaptojanin, endophilin, and clathrin. Isoforms that are expressed in muscle and ubiquitously expressed isoforms localize to the cytoplasm and nucleus and activate a caspase-independent apoptotic process. Studies in mouse suggest that this gene plays an important role in cardiac muscle development. Alternate splicing of the gene results in several transcript variants encoding different isoforms. Aberrant splice variants expressed in tumor cell lines have also been described. [provided by RefSeq, Mar 2016]
BIN1 Gene-Disease associations (from GenCC):
  • myopathy, centronuclear, 2
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • centronuclear myopathy
    Inheritance: SD Classification: DEFINITIVE Submitted by: ClinGen
  • autosomal dominant centronuclear myopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • autosomal recessive centronuclear myopathy
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0031600595).
BP6
Variant 2-127050500-G-A is Benign according to our data. Variant chr2-127050500-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 158010.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0952 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
BIN1NM_139343.3 linkc.1595C>T p.Thr532Met missense_variant Exon 18 of 19 ENST00000316724.10 NP_647593.1 O00499-1A0A024RAF1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
BIN1ENST00000316724.10 linkc.1595C>T p.Thr532Met missense_variant Exon 18 of 19 1 NM_139343.3 ENSP00000316779.5 O00499-1

Frequencies

GnomAD3 genomes
AF:
0.0284
AC:
4329
AN:
152232
Hom.:
183
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.0979
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0121
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000620
Gnomad FIN
AF:
0.000376
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.000265
Gnomad OTH
AF:
0.0282
GnomAD2 exomes
AF:
0.00752
AC:
1890
AN:
251352
AF XY:
0.00556
show subpopulations
Gnomad AFR exome
AF:
0.103
Gnomad AMR exome
AF:
0.00434
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000139
Gnomad NFE exome
AF:
0.000352
Gnomad OTH exome
AF:
0.00424
GnomAD4 exome
AF:
0.00285
AC:
4160
AN:
1461864
Hom.:
173
Cov.:
32
AF XY:
0.00245
AC XY:
1780
AN XY:
727238
show subpopulations
African (AFR)
AF:
0.100
AC:
3360
AN:
33480
American (AMR)
AF:
0.00532
AC:
238
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39698
South Asian (SAS)
AF:
0.000197
AC:
17
AN:
86256
European-Finnish (FIN)
AF:
0.0000936
AC:
5
AN:
53404
Middle Eastern (MID)
AF:
0.00503
AC:
29
AN:
5766
European-Non Finnish (NFE)
AF:
0.000125
AC:
139
AN:
1112008
Other (OTH)
AF:
0.00616
AC:
372
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.474
Heterozygous variant carriers
0
252
504
757
1009
1261
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
106
212
318
424
530
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0284
AC:
4331
AN:
152350
Hom.:
182
Cov.:
34
AF XY:
0.0271
AC XY:
2021
AN XY:
74502
show subpopulations
African (AFR)
AF:
0.0977
AC:
4061
AN:
41574
American (AMR)
AF:
0.0120
AC:
184
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5186
South Asian (SAS)
AF:
0.000621
AC:
3
AN:
4834
European-Finnish (FIN)
AF:
0.000376
AC:
4
AN:
10630
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.000265
AC:
18
AN:
68028
Other (OTH)
AF:
0.0279
AC:
59
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
201
403
604
806
1007
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
44
88
132
176
220
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00994
Hom.:
196
Bravo
AF:
0.0329
TwinsUK
AF:
0.00
AC:
0
ALSPAC
AF:
0.000259
AC:
1
ESP6500AA
AF:
0.0999
AC:
440
ESP6500EA
AF:
0.000349
AC:
3
ExAC
AF:
0.00917
AC:
1113
Asia WGS
AF:
0.00462
AC:
16
AN:
3478
EpiCase
AF:
0.000382
EpiControl
AF:
0.000533

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
-
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

May 19, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Myopathy, centronuclear, 2 Benign:2
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -

Jan 28, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.075
BayesDel_addAF
Benign
-0.53
T
BayesDel_noAF
Benign
-0.46
CADD
Uncertain
23
DANN
Uncertain
1.0
DEOGEN2
Benign
0.31
.;.;.;.;.;.;.;.;.;T;.
Eigen
Uncertain
0.32
Eigen_PC
Uncertain
0.28
FATHMM_MKL
Benign
0.68
D
LIST_S2
Uncertain
0.94
D;D;D;D;D;D;D;D;D;D;D
MetaRNN
Benign
0.0032
T;T;T;T;T;T;T;T;T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Uncertain
2.0
.;.;.;.;.;.;.;.;.;M;.
PhyloP100
1.8
PrimateAI
Uncertain
0.52
T
PROVEAN
Benign
-2.3
N;N;N;N;N;N;N;N;N;D;N
REVEL
Benign
0.14
Sift
Benign
0.032
D;D;D;D;D;D;D;D;D;D;D
Sift4G
Benign
0.092
T;T;T;T;T;T;T;T;T;T;T
Polyphen
0.86
P;P;D;P;D;P;P;P;D;P;D
Vest4
0.41
MVP
0.79
MPC
0.56
ClinPred
0.028
T
GERP RS
3.7
Varity_R
0.18
gMVP
0.32
Mutation Taster
=98/2
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs112318500; hg19: chr2-127808076; API